Statistics for Immix Biopharma, Common Stock (id:5975 IMMX)

Valuation metrics

Market cap

47.21M

Enterprise value

24.33M

Trailing P/E (ttm)

-2.01

Forward P/E

-3.13

PEG ratio

-3.13

Price/Sales (ttm)

Price/Book (mrq)

1.97

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.21

Overview

Shares outstanding

27.45M

Float

14.50M

Shares short

434.94K

% Held by insiders

0.40%

% Held by institutions

0.18%

Average volume (10 days)

68.40K

Average volume (90 days)

Price summary

52-Week low

1.26

52-Week high

7.75

52-Week change

-166.48%

Beta

0.10

50-Day moving average

1.67

200-Day moving average

2.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-56.84%

Return on equity

-103.81%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-20,180,932.00

Net income to common (ttm)

-19,022,096.00

Diluted EPS (ttm)

-0.83

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

23.98M

Total cash per share (mrq)

0.87

Total debt (mrq)

1.09M

Total Debt/Equity (mrq)

4.57

Current ratio (mrq)

700.40%

Book value per share (mrq)

0.87

Cash flow

Cash flow statement

-14,846,913.00

Levered free cash flow (LFCF)

-8,693,799.00